Liquid Biopsy Market, By Sample Type, By Biomarker, By Technology, By Product, By Clinical Application, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

REPORT HIGHLIGHT

Liquid Biopsy Market size was valued at US$ 12,124.24 Million in 2024, expanding at a CAGR of 11.6% from 2025 to 2032.

A liquid biopsy is a non-invasive diagnostic procedure that evaluates bodily fluids, mainly blood, to identify cancer or other illnesses. It analyzes biomarkers such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) to detect genetic or molecular alterations linked to a tumor. Liquid biopsies can facilitate early cancer detection, monitor the effectiveness of treatments, and evaluate tumor progression. Much of the initial research on liquid biopsies has focused on lung, breast, and prostate cancers; however, this technology is anticipated to influence all cancer types. Liquid biopsy represents a relatively recent testing method with numerous potential revolutionary applications in cancer therapy, including several uses that have received approval from the U.S. Food and Drug Administration (FDA). Ongoing research continues to explore its advantages.

Liquid Biopsy Market- Market Dynamics

The increasing prevalence of cancer is anticipated to boost the demand for early screening and therapeutics, thereby driving market growth.

As cancer emerges as a primary contributor to morbidity and mortality globally, healthcare systems are increasingly prioritizing early-stage diagnostics to detect malignancies before their advancement. This shift is propelling the utilization of sophisticated screening technologies, including liquid biopsies, imaging techniques, and molecular diagnostic assessments. The National Cancer Institute projects that by 2025, approximately 2,041,910 new cancer cases will be identified in the United States, with 618,120 fatalities attributed to the disease. Consequently, the cancer care continuum, encompassing early diagnosis through to treatment, is rapidly evolving to address the escalating healthcare demands, thereby further stimulating the market for both early screening instruments and groundbreaking therapeutics. Additionally, advancements in genomic and molecular technologies may present growth opportunities for the market. Nevertheless, the lack of standardization and regulatory hurdles could impede market expansion.

Liquid Biopsy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.6% over the forecast period (2025-2032)

Based on the Sample Type segmentation, the Blood Sample was predicted to show maximum market share in the year 2024

Based on Biomarker segmentation, Circulating Tumor Cells (CTCs) were the leading application in 2024

Based on Technology segmentation, Multi-gene-parallel Analysis (NGS) was the leading Technology in 2024

Based on Product segmentation, Instruments were the leading Product in 2024

Based on Clinical application segmentation, Therapy Selection was the leading End-User in 2024

Based on Application segmentation, Cancer was the leading End-User in 2024

Based on End-User segmentation, Hospitals and Laboratories were the leading End-User in 2024

Based on region, North America was the leading revenue generator in 2024

Liquid Biopsy Market- Segmentation Analysis:

The Global Liquid Biopsy Market is segmented based on Sample Type, Application, Technology, Product, Clinical Application, Application, End-User, and Region.

The market is categorized into three segments according to Sample Type: Blood Sample and Others. Blood Sample is the primary driver of market growth. Blood samples dominate the Liquid Biopsy sector, mainly due to their ease of collection, low invasiveness, and high levels of patient compliance. Blood-based liquid biopsies facilitate the detection and analysis of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and various other biomarkers, providing a thorough overview of the tumor's genetic profile in real-time. In comparison to tissue biopsies, blood samples offer a quicker, safer, and more economical option for cancer diagnosis, prognosis, treatment monitoring, and early detection. The extensive adoption of blood-based tests by hospitals, diagnostic centers, and research institutions further reinforces their leading position in the market.

The market is categorized into three segments based on biomarkers: Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), and Extracellular Vehicles (EVs), among others. Circulating Tumor Cells (CTCs) lead the growth of the market. CTCs are the primary drivers of growth in the Liquid Biopsy market, due to their significant role in cancer diagnosis, prognosis, and treatment monitoring. CTCs are cancer cells that separate from primary or metastatic tumors and travel through the bloodstream, providing essential insights into tumor heterogeneity and metastatic potential. Their capacity to deliver real-time data on disease progression and treatment response without requiring invasive procedures renders them a preferred biomarker in oncology.

The market is categorized into two segments based on technology: Multi-gene-parallel Analysis (NGS) and Single Gene Analysis (PCR Microarrays). Multi-gene-parallel Analysis (NGS) is the primary driver of market growth. The multi-gene parallel analysis utilising Next-Generation Sequencing (NGS) leads to the growth of the Liquid Biopsy market, owing to its capability to concurrently assess multiple genetic alterations with exceptional sensitivity and specificity. NGS facilitates extensive genomic profiling from small sample volumes, equipping clinicians with in-depth insights into tumor biology, mutation load, and possible therapeutic targets. This methodology is particularly beneficial for personalized medicine, as it enables the identification of rare mutations and resistance mechanisms in real time. The rising implementation of NGS-based liquid biopsy panels in oncology for early cancer detection, treatment selection, and monitoring of minimal residual disease is greatly enhancing the market's growth.

The market is segmented into three categories based on Product: Instruments, Consumables Kits and Reagents, and Software and Services. Instruments lead the growth of the market. Instruments are at the forefront of the Liquid Biopsy market expansion, propelled by the rising demand for sophisticated technologies that can accurately identify and analyze circulating biomarkers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and exosomes. These instruments, which include NGS platforms, PCR systems, microfluidic devices, and automated liquid handling systems, are crucial for achieving high throughput, sensitivity, and precision in diagnostic processes. The ongoing advancement of innovative, user-friendly, and integrated systems designed for oncology applications has accelerated their adoption in hospitals, diagnostic laboratories, and research institutions.

The market is categorized into four segments based on Clinical Application: Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring, and Others. Therapy Selection is the primary driver of market growth. By examining circulating tumor DNA (ctDNA) or other biomarkers, liquid biopsy facilitates the detection of specific mutations, gene fusions, and resistance mechanisms without requiring invasive tissue sampling. This method enables oncologists to customize therapies such as targeted treatments or immunotherapies according to a patient's distinct molecular profile, thereby enhancing clinical outcomes and reducing unnecessary toxicity. The increasing focus on precision medicine, coupled with the capability of liquid biopsy to track dynamic tumor alterations during treatment, further reinforces its essential role in therapy selection across different cancer types.

The market is categorized into eight segments based on application: Cancer, Reproductive Health, Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Gastrointestinal Cancer, and Others. The cancer segment is at the forefront of market growth. In the Liquid Biopsy sector, the cancer segment is driving market expansion, propelled by the increasing global prevalence of various cancers and the rising demand for non-invasive diagnostic methods. Liquid biopsy provides a revolutionary method for the early detection of cancer, tumor profiling, treatment monitoring, and predicting relapses by examining biomarkers such as ctDNA, CTCs, and exosomes derived from body fluids-mainly blood. Its benefits over conventional tissue biopsies, which include reduced risk, faster turnaround times, and the capacity to capture tumor heterogeneity, have established it as an essential instrument in oncology. As precision medicine becomes more integral to cancer treatment, the application of liquid biopsy in the management of solid tumors like lung, breast, colorectal, and prostate cancer is continually growing, further propelling the advancement of this segment.

The market is categorized into four segments based on End-User: Hospitals and Laboratories, Specialty Clinics, Academic and Research Centers, and Others. The Hospitals and Laboratories segment is at the forefront of market growth. This segment is driving the expansion of the Liquid Biopsy industry due to the increasing adoption of advanced diagnostic technologies and the growing number of cancer screening and monitoring procedures conducted in these environments. Hospitals and clinical laboratories frequently serve as the initial point of contact for patients undergoing diagnostic assessments, rendering them essential centers for the deployment of liquid biopsy tests. These institutions gain advantages from the presence of skilled professionals, established infrastructure, and access to high-throughput instruments such as NGS and PCR platforms.

Liquid Biopsy Market- Geographical Insights

North America leads in market growth, attributed to robust research and development as well as a solid reimbursement framework. The region's sophisticated healthcare system heightened awareness regarding early cancer screening, and strong partnerships between academic institutions and industry stakeholders further solidify North America's prominent role in the global liquid biopsy market. As reported by the American Medical Association, the United States allocated USD 4,866.5 billion for healthcare in 2023. Europe also orders a substantial portion of the market, bolstered by increasing cancer awareness, enhanced access to healthcare, and government funding for early detection initiatives.

Liquid Biopsy Market- Competitive Landscape:

The liquid biopsy market is characterized by intense competition and constant evolution, with numerous established and new entrants seeking to secure a competitive advantage through innovation, collaborations, and growth strategies. Firms are competing based on cutting-edge technologies such as next-generation sequencing (NGS), droplet digital PCR, and multi-gene panel testing to enhance the sensitivity, specificity, and speed of liquid biopsy assays. Leading companies are placing greater emphasis on emerging markets in the Asia Pacific and Latin America by setting up regional subsidiaries and distribution networks to seize untapped opportunities.

Recent Developments:

On November 1, 2023, Illumina Inc., a worldwide frontrunner in DNA sequencing and array-based technologies, announced the launch of a new generation of its distributed liquid biopsy assay designed for genomic profiling. The latest TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2) is a research assay that facilitates noninvasive comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) extracted from blood samples when tissue testing is not feasible, or enhances tissue-based testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIQUID BIOPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Guardant Health, Inc.
Foundation Medicine, Inc. (Roche subsidiary)
Illumina, Inc.
GRAIL, Inc. (a subsidiary of Illumina)
Bio-Rad Laboratories, Inc.
Exact Sciences Corporation
Thermo Fisher Scientific Inc.
Natera, Inc.
Freenome Holdings, Inc.
QIAGEN N.V.
Lucence Diagnostics
Inivata Ltd. (NeoGenomics subsidiary)
Angle plc
Sysmex Corporation
Biocept, Inc.
Oncocyte Corporation
Personal Genome Diagnostics (PGDx)
Chronix Biomedical
Epic Sciences, Inc.
Cynvenio Biosystems, Inc.
Others

GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

Blood Sample
Others

GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER- MARKET ANALYSIS, 2019 - 2032

Circulating Tumor Cells (CTCs)
Circulating Tumor DNA (ctDNA)
Extracellular Vehicles (EVs)
Others

GLOBAL LIQUID BIOPSY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Multi-gene-parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)

GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Instruments
Consumables Kits and Reagents
Software and Services

GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION- MARKET ANALYSIS, 2019 - 2032

Therapy Selection
Treatment Monitoring
Early Cancer Screening
Recurrence Monitoring
Others

GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cancer
Reproductive Health
Lung Cancer
Prostate Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Gastrointestinal Cancer
Others

GLOBAL LIQUID BIOPSY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals and Laboratories
Specialty Clinics
Academic and Research Centers
Others

GLOBAL LIQUID BIOPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5421

1. Liquid Biopsy Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Liquid Biopsy Market Snippet by Sample Type
- 2.1.2. Liquid Biopsy Market Snippet by Biomarker
- 2.1.3. Liquid Biopsy Market Snippet by Technology
- 2.1.4. Liquid Biopsy Market Snippet by Product
- 2.1.5. Liquid Biopsy Market Snippet by Clinical Application
- 2.1.6. Liquid Biopsy Market Snippet by Application
- 2.1.7. Liquid Biopsy Market Snippet by End-User
- 2.1.8. Liquid Biopsy Market Snippet by Country
- 2.1.9. Liquid Biopsy Market Snippet by Region
2.2. Competitive Insights

3. Liquid Biopsy Key Market Trends

3.1. Liquid Biopsy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Liquid Biopsy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Liquid Biopsy Market Opportunities
3.4. Liquid Biopsy Market Future Trends

4. Liquid Biopsy Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Liquid Biopsy Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Liquid Biopsy Market Landscape

6.1. Liquid Biopsy Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Liquid Biopsy Market - By Sample Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
- 7.1.2. Blood Sample
- 7.1.3. Others

8. Liquid Biopsy Market - By Biomarker

8.1. Overview
- 8.1.1. Segment Share Analysis, By Biomarker, 2024 & 2032 (%)
- 8.1.2. Circulating Tumor Cells (CTCs)
- 8.1.3. Circulating Tumor DNA (ctDNA)
- 8.1.4. Extracellular Vehicles (EVs)
- 8.1.5. Others

9. Liquid Biopsy Market - By Technology

9.1. Overview
- 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 9.1.2. Multi-gene-parallel Analysis (NGS)
- 9.1.3. Single Gene Analysis (PCR Microarrays)

10. Liquid Biopsy Market - By Product

10.1. Overview
- 10.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 10.1.2. Instruments
- 10.1.3. Consumables Kits and Reagents
- 10.1.4. Software and Services

11. Liquid Biopsy Market - By Clinical Application

11.1. Overview
- 11.1.1. Segment Share Analysis, By Clinical Application, 2024 & 2032 (%)
- 11.1.2. Therapy Selection
- 11.1.3. Treatment Monitoring
- 11.1.4. Early Cancer Screening
- 11.1.5. Recurrence Monitoring
- 11.1.6. Others

12. Liquid Biopsy Market - By Application

12.1. Overview
- 12.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 12.1.2. Cancer
- 12.1.3. Reproductive Health
- 12.1.4. Lung Cancer
- 12.1.5. Prostate Cancer
- 12.1.6. Breast Cancer
- 12.1.7. Colorectal Cancer
- 12.1.8. Leukemia
- 12.1.9. Gastrointestinal Cancer
- 12.1.10. Others

13. Liquid Biopsy Market - By End-User

13.1. Overview
- 13.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
- 13.1.2. Hospitals and Laboratories
- 13.1.3. Specialty Clinics
- 13.1.4. Academic and Research Centers
- 13.1.5. Others

14. Liquid Biopsy Market- By Geography

14.1. Introduction
- 14.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
14.2. North America
- 14.2.1. Overview
- 14.2.2. Liquid Biopsy Key Manufacturers in North America
- 14.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.2.4. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 14.2.5. North America Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
- 14.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 14.2.7. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 14.2.8. North America Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
- 14.2.9. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.2.10. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.2.11. U.S.
  - 14.2.11.1. Overview
  - 14.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.2.11.3. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.2.11.4. U.S. Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.2.11.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.2.11.6. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.2.11.7. U.S. Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.2.11.8. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.2.11.9. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.2.12. Canada
  - 14.2.12.1. Overview
  - 14.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.2.12.3. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.2.12.4. Canada Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.2.12.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.2.12.6. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.2.12.7. Canada Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.2.12.8. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.2.12.9. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
14.3. Europe
- 14.3.1. Overview
- 14.3.2. Liquid Biopsy Key Manufacturers in Europe
- 14.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.3.4. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 14.3.5. Europe Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
- 14.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 14.3.7. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 14.3.8. Europe Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
- 14.3.9. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.10. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.11. Germany
  - 14.3.11.1. Overview
  - 14.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.11.3. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.11.4. Germany Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.11.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.11.6. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.11.7. Germany Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.11.8. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.11.9. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.12. UK
  - 14.3.12.1. Overview
  - 14.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.12.3. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.12.4. UK Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.12.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.12.6. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.12.7. UK Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.12.8. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.12.9. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.13. France
  - 14.3.13.1. Overview
  - 14.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.13.3. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.13.4. France Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.13.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.13.6. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.13.7. France Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.13.8. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.13.9. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.14. Italy
  - 14.3.14.1. Overview
  - 14.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.14.3. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.14.4. Italy Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.14.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.14.6. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.14.7. Italy Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.14.8. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.14.9. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.15. Spain
  - 14.3.15.1. Overview
  - 14.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.15.3. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.15.4. Spain Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.15.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.15.6. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.15.7. Spain Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.15.8. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.15.9. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.16. The Netherlands
  - 14.3.16.1. Overview
  - 14.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.16.3. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.16.4. The Netherlands Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.16.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.16.6. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.16.7. The Netherlands Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.16.8. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.16.9. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.17. Sweden
  - 14.3.17.1. Overview
  - 14.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.17.3. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.17.4. Sweden Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.17.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.17.6. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.17.7. Sweden Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.17.8. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.17.9. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.18. Russia
  - 14.3.18.1. Overview
  - 14.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.18.3. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.18.4. Russia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.18.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.18.6. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.18.7. Russia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.18.8. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.18.9. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.19. Poland
  - 14.3.19.1. Overview
  - 14.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.19.3. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.19.4. Poland Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.19.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.19.6. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.19.7. Poland Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.19.8. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.19.9. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.3.20. Rest of Europe
  - 14.3.20.1. Overview
  - 14.3.20.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.20.3. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.3.20.4. Rest of the Europe Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.3.20.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.3.20.6. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.3.20.7. Rest of the Europe Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.3.20.8. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.20.9. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
14.4. Asia Pacific (APAC)
- 14.4.1. Overview
- 14.4.2. Liquid Biopsy Key Manufacturers in Asia Pacific
- 14.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.4.4. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 14.4.5. APAC Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
- 14.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 14.4.7. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 14.4.8. APAC Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
- 14.4.9. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.10. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.4.11. China
  - 14.4.11.1. Overview
  - 14.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.11.3. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.4.11.4. China Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.4.11.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.4.11.6. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.4.11.7. China Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.4.11.8. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.11.9. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.4.12. India
  - 14.4.12.1. Overview
  - 14.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.12.3. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.4.12.4. India Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.4.12.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.4.12.6. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.4.12.7. India Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.4.12.8. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.12.9. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.4.13. Japan
  - 14.4.13.1. Overview
  - 14.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.13.3. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.4.13.4. Japan Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.4.13.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.4.13.6. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.4.13.7. Japan Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.4.13.8. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.13.9. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.4.14. South Korea
  - 14.4.14.1. Overview
  - 14.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.14.3. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.4.14.4. South Korea Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.4.14.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.4.14.6. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.4.14.7. South Korea Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.4.14.8. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.14.9. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.4.15. Australia
  - 14.4.15.1. Overview
  - 14.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.15.3. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.4.15.4. Australia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.4.15.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.4.15.6. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.4.15.7. Australia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.4.15.8. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.15.9. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.4.16. Indonesia
  - 14.4.16.1. Overview
  - 14.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.16.3. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.4.16.4. Indonesia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.4.16.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.4.16.6. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.4.16.7. Indonesia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.4.16.8. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.16.9. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.4.17. Thailand
  - 14.4.17.1. Overview
  - 14.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.17.3. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.4.17.4. Thailand Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.4.17.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.4.17.6. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.4.17.7. Thailand Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.4.17.8. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.17.9. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.4.18. Philippines
  - 14.4.18.1. Overview
  - 14.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.18.3. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.4.18.4. Philippines Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.4.18.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.4.18.6. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.4.18.7. Philippines Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.4.18.8. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.18.9. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.4.19. Rest of APAC
  - 14.4.19.1. Overview
  - 14.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.19.3. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.4.19.4. Rest of APAC Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.4.19.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.4.19.6. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.4.19.7. Rest of APAC Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.4.19.8. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.19.9. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
14.5. Latin America (LATAM)
- 14.5.1. Overview
- 14.5.2. Liquid Biopsy Key Manufacturers in Latin America
- 14.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.5.4. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 14.5.5. LATAM Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
- 14.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 14.5.7. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 14.5.8. LATAM Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
- 14.5.9. LATAM Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.5.10. LATAM Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.5.11. Brazil
  - 14.5.11.1. Overview
  - 14.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.11.3. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.5.11.4. Brazil Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.5.11.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.5.11.6. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.5.11.7. Brazil Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.5.11.8. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.11.9. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.5.12. Mexico
  - 14.5.12.1. Overview
  - 14.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.12.3. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.5.12.4. Mexico Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.5.12.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.5.12.6. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.5.12.7. Mexico Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.5.12.8. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.12.9. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.5.13. Argentina
  - 14.5.13.1. Overview
  - 14.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.13.3. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.5.13.4. Argentina Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.5.13.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.5.13.6. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.5.13.7. Argentina Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.5.13.8. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.13.9. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.5.14. Colombia
  - 14.5.14.1. Overview
  - 14.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.14.3. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.5.14.4. Colombia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.5.14.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.5.14.6. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.5.14.7. Colombia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.5.14.8. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.14.9. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.5.15. Rest of LATAM
  - 14.5.15.1. Overview
  - 14.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.15.3. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.5.15.4. Rest of LATAM Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.5.15.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.5.15.6. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.5.15.7. Rest of LATAM Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.5.15.8. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.15.9. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
14.6. Middle East and Africa
- 14.6.1. Overview
- 14.6.2. Liquid Biopsy Key Manufacturers in Middle East and Africa
- 14.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.6.4. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 14.6.5. Middle East and Africa Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
- 14.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 14.6.7. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 14.6.8. Middle East and Africa Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
- 14.6.9. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.10. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.6.11. Saudi Arabia
  - 14.6.11.1. Overview
  - 14.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.11.3. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.6.11.4. Saudi Arabia Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.6.11.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.6.11.6. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.6.11.7. Saudi Arabia Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.6.11.8. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.11.9. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.6.12. United Arab Emirates
  - 14.6.12.1. Overview
  - 14.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.12.3. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.6.12.4. United Arab Emirates Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.6.12.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.6.12.6. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.6.12.7. United Arab Emirates Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.6.12.8. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.12.9. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.6.13. Israel
  - 14.6.13.1. Overview
  - 14.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.13.3. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.6.13.4. Israel Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.6.13.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.6.13.6. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.6.13.7. Israel Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.6.13.8. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.13.9. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.6.14. Turkey
  - 14.6.14.1. Overview
  - 14.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.14.3. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.6.14.4. Turkey Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.6.14.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.6.14.6. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.6.14.7. Turkey Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.6.14.8. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.14.9. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.6.15. Algeria
  - 14.6.15.1. Overview
  - 14.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.15.3. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.6.15.4. Algeria Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.6.15.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.6.15.6. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.6.15.7. Algeria Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.6.15.8. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.15.9. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.6.16. Egypt
  - 14.6.16.1. Overview
  - 14.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.16.3. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.6.16.4. Egypt Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.6.16.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.6.16.6. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.6.16.7. Egypt Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.6.16.8. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.16.9. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 14.6.17. Rest of MEA
  - 14.6.17.1. Overview
  - 14.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.17.3. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 14.6.17.4. Rest of MEA Market Size and Forecast, By Biomarker, 2019 - 2032 (US$ Million)
  - 14.6.17.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 14.6.17.6. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 14.6.17.7. Rest of MEA Market Size and Forecast, By Clinical Application, 2019 - 2032 (US$ Million)
  - 14.6.17.8. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.17.9. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

15. Key Vendor Analysis- Liquid Biopsy Industry

15.1. Competitive Dashboard
- 15.1.1. Competitive Benchmarking
- 15.1.2. Competitive Positioning
15.2. Company Profiles
- 15.2.1. Guardant Health, Inc.
- 15.2.2. Foundation Medicine, Inc. (Roche subsidiary)
- 15.2.3. Illumina, Inc.
- 15.2.4. GRAIL, Inc. (subsidiary of Illumina)
- 15.2.5. Bio-Rad Laboratories, Inc.
- 15.2.6. Exact Sciences Corporation
- 15.2.7. Thermo Fisher Scientific Inc.
- 15.2.8. Natera, Inc.
- 15.2.9. Freenome Holdings, Inc.
- 15.2.10. QIAGEN N.V.
- 15.2.11. Lucence Diagnostics
- 15.2.12. Inivata Ltd. (NeoGenomics subsidiary)
- 15.2.13. Angle plc
- 15.2.14. Sysmex Corporation
- 15.2.15. Biocept, Inc.
- 15.2.16. Oncocyte Corporation
- 15.2.17. Personal Genome Diagnostics (PGDx)
- 15.2.18. Chronix Biomedical
- 15.2.19. Epic Sciences, Inc.
- 15.2.20. Cynvenio Biosystems, Inc.
- 15.2.21. Others

16. 360 Degree Analyst View

17. Appendix

17.1. Research Methodology
17.2. References
17.3. Abbreviations
17.4. Disclaimer
17.5. Contact Us